Quantcast

High court will hear Actos failure-to-warn appeal

With more than $1.75 million at stake, Maryland’s top court said it will consider whether a pharmaceutical company should be held financially liable for negligently failing to warn doctors about a drug’s potentially carcinogenic side effect even though the cancer victim contributed to the fatal disease by smoking cigarettes.

Leave a Reply

Your email address will not be published. Required fields are marked *

*